UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

Oxford Immunotec Global PLC

(Name of Issuer)

Common Stock

(Title of Class of Securities)

G6855A103*

(CUSIP Number)

January 31, 2021

(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
☒   Rule 13d-1(b)
☐   Rule 13d-1(c)
☐   Rule 13d-1(d)

* CUSIP number not available. CINS provided.

The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


CUSIP No. G6855A103				13G	Page 2 of 5 Pages


1.	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Grandeur Peak Global Advisors, LLC 90-0732232
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) ☐ (b) ☐
3.	SEC USE ONLY
4.	CITIZENSHIP OR PLACE OF ORGANIZATION Utah

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5.	SOLE VOTING POWER 570,836
		6.	SHARED VOTING POWER -0-
		7.	SOLE DISPOSITIVE POWER 570,836
		8.	SHARED DISPOSITIVE POWER -0-

9.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 570,836
10.	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions) ☐
11.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 2.23%
12.	TYPE OF REPORTING PERSON (see instructions) IA


CUSIP No. G6855A103	13G	Page 3 of 5 Pages

Item 1.

	(a)	Name of Issuer Oxford Immunotec Global

	(b)	Address of Issuer’s Principal Executive Offices 700 Nickerson Road, Suite 200 Marlborough, MA 01752

Item 2.

	(a)	Name of Person Filing Grandeur Peak Global Advisors, LLC

	(b)	Address of the Principal Office or, if none, residence 136 South Main Street, Suite 720 Salt Lake City, UT 84101

	(c)	Citizenship Not Applicable

	(d)	Title of Class of Securities Common Stock

	(e)	CUSIP Number G6855A103

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

(e) [X] An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

Item 4. Ownership.

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.


(a)	Amount beneficially owned: 570,836

(b)	Percent of class: 2.23%

(c)	Number of shares as to which the person has:

	(i)	Sole power to vote or to direct the vote 570,836

	(ii)	Shared power to vote or to direct the vote -0-

	(iii)	Sole power to dispose or to direct the disposition of 570,836

	(iv)	Shared power to dispose or to direct the disposition of -0-

Item 5. Ownership of Five Percent or Less of a Class.

As of January 31, 2021 the beneficial interest decreased more than 5% since the previous filing. Issuer was acquired on March 9, 2021.

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

Not Applicable.

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

Not Applicable.

Item 8. Identification and Classification of Members of the Group.

Not Applicable.

Item 9. Notice of Dissolution of Group.

Not Applicable.

Item 10. Certification.

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.


CUSIP No. G6855A103	13G	Page 5 of 5 Pages

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

	5/7/2021
	Date

	/s/ Amy Hone
	Signature

	Amy Hone / Deputy CCO
	Name/Title

Oxford Immunotec Global PLC SC 13G